{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:23:15Z","timestamp":1793413395896,"version":"4.5.0"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12072-026-11116-1","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:37:19Z","timestamp":1785425839000},"page":"963-991","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper"],"prefix":"10.1007","volume":"20","author":[{"given":"Tao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaigham","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramazan","family":"Idilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemal Fariz","family":"Kalista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosmawati Binti","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elbasiony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasitha S.","family":"Wijewantha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Panackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kessarin","family":"Thanapirom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khin Maung","family":"Win","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L.","family":"Shawcross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot B.","family":"Tapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananta","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Kadir","family":"Dokmeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand V.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gupse","family":"Adali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawesak","family":"Tanwandee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Mamun-Al-Mahtab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmas Rinaldi A.","family":"Lesmana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Kabacam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipun","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna Subhan","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakkarin","family":"Chirapongsathorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Maiwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. K.","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmohan","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Yaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barjesh Chander","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Valsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine J.","family":"Karvellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Kamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjaya K.","family":"Satapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor G.","family":"Bakulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Asrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasmik","family":"Ghazinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imelda Maria","family":"Loho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Alcantara","family":"Payawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Hernaez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruveena Bhawani","family":"Rajaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suprabhat","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madunil A.","family":"Niriella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Dadhich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Golam","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhosh E.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Wai-Sun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahinul","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Lung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh K.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal E.","family":"Shiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soek Siam","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra Singh","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Rela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C. Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Bhangui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Dhinesh","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamatha","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Saigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal Hamdy","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necati","family":"Ormeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Omata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Y.","family":"Kwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv Kumar","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2027-9593","authenticated-orcid":false,"given":"Qin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"APASL-ACLF Research Consortium (AARC) for APASL-ACLF Working Party","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"1","key":"11116_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-024-10773-4","volume":"19","author":"A Choudhury","year":"2025","unstructured":"Choudhury A, et al. Acute-on-chronic liver failure (ACLF): the \u2019Kyoto Consensus\u2019-steps from Asia. Hepatol Int. 2025;19(1):1\u201369","journal-title":"Hepatol Int"},{"key":"11116_CR2","doi-asserted-by":"crossref","unstructured":"Moreau R, et al. EASL clinical practice guidelines on acute-on-chronic liver failure. J Hepatol. 2023;79(2):461\u2013491","DOI":"10.1016\/j.jhep.2023.04.021"},{"issue":"6","key":"11116_CR3","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/HEP.0000000000000671","volume":"79","author":"CJ Karvellas","year":"2024","unstructured":"Karvellas CJ, et al. AASLD practice guidance on acute-on-chronic liver failure and the management of critically ill patients with cirrhosis. Hepatology. 2024;79(6):1463\u20131502","journal-title":"Hepatology"},{"issue":"4","key":"11116_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jhep.2018.09.015","volume":"70","author":"A Ferrarese","year":"2019","unstructured":"Ferrarese A, et al. Outcome of critically ill cirrhotic patients admitted to the ICU: the role of ACLF. J Hepatol. 2019;70(4):801\u2013803","journal-title":"J Hepatol"},{"issue":"1","key":"11116_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/hep.27849","volume":"62","author":"T Gustot","year":"2015","unstructured":"Gustot T, et al. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62(1):243\u2013252","journal-title":"Hepatology"},{"issue":"3","key":"11116_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jhep.2021.03.030","volume":"75","author":"LS Belli","year":"2021","unstructured":"Belli LS, et al. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA\/EF-CLIF collaborative study (ECLIS). J Hepatol. 2021;75(3):610\u2013622","journal-title":"J Hepatol"},{"issue":"1","key":"11116_CR7","doi-asserted-by":"publisher","first-page":"30497","DOI":"10.1038\/s41598-024-82178-0","volume":"14","author":"MR Pollmanns","year":"2024","unstructured":"Pollmanns MR, et al. The Aachen ACLF ICU score predicts ICU mortality in critically ill patients with acute-on-chronic liver failure. Sci Rep. 2024;14(1):30497","journal-title":"Sci Rep"},{"issue":"5","key":"11116_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jhep.2011.12.014","volume":"56","author":"DL Shawcross","year":"2012","unstructured":"Shawcross DL, et al. The impact of organ dysfunction in cirrhosis: survival at a cost? J Hepatol. 2012;56(5):1054\u20131062","journal-title":"J Hepatol"},{"issue":"5","key":"11116_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/CCM.0000000000002961","volume":"46","author":"MJW McPhail","year":"2018","unstructured":"McPhail MJW, et al. Incidence and outcomes for patients with cirrhosis admitted to the United Kingdom Critical Care Units. Crit Care Med. 2018;46(5):705\u2013712","journal-title":"Crit Care Med"},{"issue":"1","key":"11116_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/1751143720978849","volume":"23","author":"NN Passi","year":"2022","unstructured":"Passi NN, McPhail MJ. The patient with cirrhosis in the intensive care unit and the management of acute-on-chronic liver failure. J Intensive Care Soc. 2022;23(1):78\u201386","journal-title":"J Intensive Care Soc"},{"issue":"7","key":"11116_CR11","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426\u20131437 (1437.e1\u20139)","journal-title":"Gastroenterology"},{"issue":"22","key":"11116_CR12","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1056\/NEJMra1914900","volume":"382","author":"V Arroyo","year":"2020","unstructured":"Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020;382(22):2137\u20132145","journal-title":"N Engl J Med"},{"issue":"10","key":"11116_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100529","volume":"4","author":"T Wang","year":"2022","unstructured":"Wang T, et al. Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis. JHEP Rep. 2022;4(10): 100529","journal-title":"JHEP Rep"},{"issue":"4","key":"11116_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","volume":"73","author":"J Trebicka","year":"2020","unstructured":"Trebicka J, et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol. 2020;73(4):842\u2013854","journal-title":"J Hepatol"},{"issue":"3","key":"11116_CR15","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s40121-021-00454-2","volume":"10","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, et al. Development and validation of a clinical predictive model for bacterial infection in hepatitis B virus-related acute-on-chronic liver failure. Infect Dis Ther. 2021;10(3):1347\u20131361","journal-title":"Infect Dis Ther"},{"issue":"1","key":"11116_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12072-021-10268-6","volume":"16","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, et al. Establishment and validation of a prognostic model for hepatitis B virus-related acute-on-chronic liver failure patients with bacterial infection. Hepatol Int. 2022;16(1):38\u201347","journal-title":"Hepatol Int"},{"issue":"5","key":"11116_CR17","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jhep.2023.07.011","volume":"79","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes. J Hepatol. 2023;79(5):1159\u20131171","journal-title":"J Hepatol"},{"issue":"8","key":"11116_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1136\/gutjnl-2024-333876","volume":"74","author":"J Trebicka","year":"2025","unstructured":"Trebicka J, et al. Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis. Gut. 2025;74(8):1293\u20131307","journal-title":"Gut"},{"key":"11116_CR19","doi-asserted-by":"publisher","first-page":"32341","DOI":"10.1038\/srep32341","volume":"6","author":"C Sol\u00e9","year":"2016","unstructured":"Sol\u00e9 C, et al. Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis. Sci Rep. 2016;6:32341","journal-title":"Sci Rep"},{"issue":"4","key":"11116_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10620-008-0421-9","volume":"54","author":"A Kumar","year":"2009","unstructured":"Kumar A, et al. Hemodynamic studies in acute-on-chronic liver failure. Dig Dis Sci. 2009;54(4):869\u2013878","journal-title":"Dig Dis Sci"},{"issue":"1","key":"11116_CR21","first-page":"42","volume":"8","author":"AV Kulkarni","year":"2020","unstructured":"Kulkarni AV, et al. Pathophysiology and prevention of paracentesis-induced circulatory dysfunction: a concise review. J Clin Transl Hepatol. 2020;8(1):42\u201348","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"11116_CR22","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/hep.31071","volume":"72","author":"V Arora","year":"2020","unstructured":"Arora V, et al. Paracentesis-induced circulatory dysfunction with modest-volume paracentesis is partly ameliorated by albumin infusion in acute-on-chronic liver failure. Hepatology. 2020;72(3):1043\u20131055","journal-title":"Hepatology"},{"key":"11116_CR23","doi-asserted-by":"crossref","unstructured":"Turgut F, Awad AS, Abdel-Rahman EM. Acute kidney injury: medical causes and pathogenesis. J Clin Med. 2023;12(1)","DOI":"10.3390\/jcm12010375"},{"issue":"11","key":"11116_CR24","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2215\/CJN.03040322","volume":"17","author":"G Cullaro","year":"2022","unstructured":"Cullaro G, Kanduri SR, Velez JCQ. Acute kidney injury in patients with liver disease. Clin J Am Soc Nephrol. 2022;17(11):1674\u20131684","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"11116_CR25","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1007\/s10620-024-08423-8","volume":"69","author":"A Jindal","year":"2024","unstructured":"Jindal A, et al. Early versus standard initiation of terlipressin for acute kidney injury in ACLF: a randomized controlled trial (eTerli Study). Dig Dis Sci. 2024;69(6):2204\u20132214","journal-title":"Dig Dis Sci"},{"issue":"2","key":"11116_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/17474124.2025.2456121","volume":"19","author":"R Maiwall","year":"2025","unstructured":"Maiwall R, Sharma F. AKI in ACLF: navigating the complex therapeutic puzzle. Expert Rev Gastroenterol Hepatol. 2025;19(2):165\u2013180","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"11116_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/cld.799","volume":"14","author":"S Piano","year":"2019","unstructured":"Piano S, Angeli P. Current concepts on bacterial and fungal infections in cirrhosis. Clin Liver Dis (Hoboken). 2019;14(3):87\u201391","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"6","key":"11116_CR28","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","volume":"60","author":"R Jalan","year":"2014","unstructured":"Jalan R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL special conference 2013. J Hepatol. 2014;60(6):1310\u20131324","journal-title":"J Hepatol"},{"issue":"3","key":"11116_CR29","first-page":"257","volume":"12","author":"S Qiu","year":"2024","unstructured":"Qiu S, et al. Impact of onset time, number, type, and sequence of extrahepatic organ failure on prognosis of acute-on-chronic liver failure. J Clin Transl Hepatol. 2024;12(3):257\u2013265","journal-title":"J Clin Transl Hepatol"},{"issue":"5","key":"11116_CR30","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jhep.2020.11.019","volume":"74","author":"J Trebicka","year":"2021","unstructured":"Trebicka J, et al. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. J Hepatol. 2021;74(5):1097\u20131108","journal-title":"J Hepatol"},{"issue":"18","key":"11116_CR31","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1001\/jama.2023.4902","volume":"329","author":"A Louvet","year":"2023","unstructured":"Louvet A, et al. Effect of prophylactic antibiotics on mortality in severe alcohol-related hepatitis: a randomized clinical trial. JAMA. 2023;329(18):1558\u20131566","journal-title":"JAMA"},{"issue":"1","key":"11116_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.14309\/ajg.0000000000001937","volume":"118","author":"R Kutmutia","year":"2023","unstructured":"Kutmutia R, et al. Evaluating the role of antibiotics in patients admitted to hospital with decompensated cirrhosis: lessons from the ATTIRE trial. Am J Gastroenterol. 2023;118(1):105\u2013113","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"11116_CR33","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jhep.2021.06.035","volume":"75","author":"A Granito","year":"2021","unstructured":"Granito A, Muratori P, Muratori L. Acute-on-chronic liver failure: a complex clinical entity in patients with autoimmune hepatitis. J Hepatol. 2021;75(6):1503\u20131505","journal-title":"J Hepatol"},{"issue":"3","key":"11116_CR34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2015.04.004","volume":"63","author":"C Elia","year":"2015","unstructured":"Elia C, et al. Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: a case-control study. J Hepatol. 2015;63(3):593\u2013600","journal-title":"J Hepatol"},{"issue":"4","key":"11116_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","volume":"71","author":"P Angeli","year":"2019","unstructured":"Angeli P, et al. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J Hepatol. 2019;71(4):811\u2013822","journal-title":"J Hepatol"},{"key":"11116_CR36","doi-asserted-by":"publisher","first-page":"1743290","DOI":"10.1155\/2019\/1743290","volume":"2019","author":"WF Hsu","year":"2019","unstructured":"Hsu WF, et al. Renal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with liver cirrhosis: a nationwide cohort study. Gastroenterol Res Pract. 2019;2019:1743290","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"11116_CR37","doi-asserted-by":"publisher","first-page":"17486","DOI":"10.1038\/s41598-023-44299-w","volume":"13","author":"TL Tergast","year":"2023","unstructured":"Tergast TL, et al. Effects of renin-angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis. Sci Rep. 2023;13(1):17486","journal-title":"Sci Rep"},{"issue":"8","key":"11116_CR38","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1111\/liv.12786","volume":"35","author":"T Serst\u00e9","year":"2015","unstructured":"Serst\u00e9 T, et al. The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis. Liver Int. 2015;35(8):1974\u20131982","journal-title":"Liver Int"},{"issue":"11","key":"11116_CR39","doi-asserted-by":"publisher","first-page":"e1040","DOI":"10.1097\/CCM.0000000000003356","volume":"46","author":"I Barjaktarevic","year":"2018","unstructured":"Barjaktarevic I, et al. Ultrasound assessment of the change in carotid corrected flow time in fluid responsiveness in undifferentiated shock. Crit Care Med. 2018;46(11):e1040\u2013e1046","journal-title":"Crit Care Med"},{"issue":"9","key":"11116_CR40","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa2008290","volume":"384","author":"F Wong","year":"2021","unstructured":"Wong F, et al. Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. N Engl J Med. 2021;384(9):818\u2013828","journal-title":"N Engl J Med"},{"issue":"5","key":"11116_CR41","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s12072-016-9756-z","volume":"10","author":"H Zang","year":"2016","unstructured":"Zang H, et al. Incidence, risk factors and outcomes of acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF) of underlying cirrhosis. Hepatol Int. 2016;10(5):807\u2013818","journal-title":"Hepatol Int"},{"issue":"3","key":"11116_CR42","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12072-024-10650-0","volume":"18","author":"R Maiwall","year":"2024","unstructured":"Maiwall R, et al. APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure. Hepatol Int. 2024;18(3):833\u2013869","journal-title":"Hepatol Int"},{"issue":"Suppl 2","key":"11116_CR43","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s12072-024-10711-4","volume":"18","author":"A Choudhury","year":"2024","unstructured":"Choudhury A, Rajaram R, Sarin SK. Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier. Hepatol Int. 2024;18(Suppl 2):941\u2013958","journal-title":"Hepatol Int"},{"issue":"Suppl","key":"11116_CR44","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32\u2013S50","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"11116_CR45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jhep.2018.04.016","volume":"69","author":"V Sundaram","year":"2018","unstructured":"Sundaram V, et al. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis. J Hepatol. 2018;69(3):617\u2013625","journal-title":"J Hepatol"},{"issue":"11\u201312","key":"11116_CR46","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/apt.13426","volume":"42","author":"V Sundaram","year":"2015","unstructured":"Sundaram V, et al. Obesity is independently associated with infection in hospitalised patients with end-stage liver disease. Aliment Pharmacol Ther. 2015;42(11\u201312):1271\u20131280","journal-title":"Aliment Pharmacol Ther"},{"issue":"23","key":"11116_CR47","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.3748\/wjg.v27.i23.3372","volume":"27","author":"RM Lai","year":"2021","unstructured":"Lai RM, et al. Effect of type 2 diabetic mellitus in the prognosis of acute-on-chronic liver failure patients in China. World J Gastroenterol. 2021;27(23):3372\u20133385","journal-title":"World J Gastroenterol"},{"issue":"4","key":"11116_CR48","doi-asserted-by":"publisher","first-page":"816","DOI":"10.14309\/ajg.0000000000002951","volume":"120","author":"A Kumar","year":"2025","unstructured":"Kumar A, et al. Impact of diabetes, drug-induced liver injury, and sepsis on outcomes in metabolic dysfunction associated fatty liver disease-related acute-on-chronic liver failure. Am J Gastroenterol. 2025;120(4):816\u2013826","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"11116_CR49","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/liv.14671","volume":"41","author":"A Duseja","year":"2021","unstructured":"Duseja A, et al. Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure. Liver Int. 2021;41(1):150\u2013157","journal-title":"Liver Int"},{"issue":"3","key":"11116_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15659","volume":"45","author":"CJ Karvellas","year":"2025","unstructured":"Karvellas CJ, Gustot T, Fernandez J. Management of the acute on chronic liver failure in the intensive care unit. Liver Int. 2025;45(3): e15659","journal-title":"Liver Int"},{"issue":"3","key":"11116_CR51","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/TP.0000000000003867","volume":"106","author":"L Brodosi","year":"2022","unstructured":"Brodosi L, et al. Management of diabetes in candidates for liver transplantation and in transplant recipients. Transplantation. 2022;106(3):462\u2013478","journal-title":"Transplantation"},{"key":"11116_CR52","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts. 2024;17(4):374\u2013444","DOI":"10.1159\/000539371"},{"key":"11116_CR53","doi-asserted-by":"crossref","unstructured":"Samuel D, et al. EASL clinical practice guidelines on liver transplantation. J Hepatol. 2024;81(6):1040\u20131086","DOI":"10.1016\/j.jhep.2024.07.032"},{"issue":"5","key":"11116_CR54","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/jam.14862","volume":"130","author":"N.K. Abd El-Aziz","year":"2021","unstructured":"N.K. Abd El\u2010Aziz, et al. Real-time PCR versus MALDI-TOF MS and culture-based techniques for diagnosis of bloodstream and pyogenic infections in humans and animals. J Appl Microbiol. 2021;130(5):1630\u20131644","journal-title":"J Appl Microbiol"},{"key":"11116_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101012","volume":"71","author":"C de la Fuente-Nunez","year":"2023","unstructured":"de la Fuente-Nunez C, Cesaro A, Hancock REW. Antibiotic failure: beyond antimicrobial resistance. Drug Resist Updat. 2023;71: 101012","journal-title":"Drug Resist Updat"},{"issue":"7","key":"11116_CR56","first-page":"667","volume":"12","author":"Z Xu","year":"2024","unstructured":"Xu Z, et al. Bacterial infections in acute-on-chronic liver failure: epidemiology, diagnosis, pathogenesis, and management. J Clin Transl Hepatol. 2024;12(7):667\u2013676","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"11116_CR57","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s12072-023-10637-3","volume":"18","author":"T Chen","year":"2024","unstructured":"Chen T, et al. Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections. Hepatol Int. 2024;18(3):817\u2013832","journal-title":"Hepatol Int"},{"issue":"4","key":"11116_CR58","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353\u2013390","journal-title":"Hepatol Int"},{"issue":"8","key":"11116_CR59","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S2468-1253(24)00078-5","volume":"9","author":"S Piano","year":"2024","unstructured":"Piano S, et al. Infections in cirrhosis. Lancet Gastroenterol Hepatol. 2024;9(8):745\u2013757","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"11116_CR60","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/myc.13387","volume":"65","author":"N Verma","year":"2022","unstructured":"Verma N, et al. Global epidemiological burden of fungal infections in cirrhosis patients: a systematic review with meta-analysis. Mycoses. 2022;65(3):266\u2013284","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"11116_CR61","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.jhep.2020.11.010","volume":"75","author":"J Fern\u00e1ndez","year":"2021","unstructured":"Fern\u00e1ndez J, et al. Management of bacterial and fungal infections in cirrhosis: the MDRO challenge. J Hepatol. 2021;75(Suppl 1):S101-s117","journal-title":"J Hepatol"},{"issue":"10","key":"11116_CR62","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","volume":"67","author":"J Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez J, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2018;67(10):1870\u20131880","journal-title":"Gut"},{"issue":"4","key":"11116_CR63","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/ajg.2017.471","volume":"113","author":"JS Bajaj","year":"2018","unstructured":"Bajaj JS, et al. Prediction of fungal infection development and their impact on survival using the NACSELD cohort. Am J Gastroenterol. 2018;113(4):556\u2013563","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"11116_CR64","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cmi.2020.04.030","volume":"27","author":"M Bartoletti","year":"2021","unstructured":"Bartoletti M, et al. Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case-control-control study. Clin Microbiol Infect. 2021;27(2):276\u2013282","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"11116_CR65","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","volume":"72","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, et al. EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the Intensive Care Unit Working Group. Clin Infect Dis. 2021;72(Suppl 2):S121-s127","journal-title":"Clin Infect Dis"},{"issue":"24","key":"11116_CR66","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMra2021808","volume":"384","author":"JS Bajaj","year":"2021","unstructured":"Bajaj JS, Kamath PS, Reddy KR. The evolving challenge of infections in cirrhosis. N Engl J Med. 2021;384(24):2317\u20132330","journal-title":"N Engl J Med"},{"key":"11116_CR67","doi-asserted-by":"crossref","unstructured":"Kluge S, et al. Aspergillosis: emerging risk groups in critically ill patients. Med Mycol. 2021;60(1)","DOI":"10.1093\/mmy\/myab064"},{"issue":"2","key":"11116_CR68","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/myc.13403","volume":"65","author":"T Lahmer","year":"2022","unstructured":"Lahmer T, et al. Invasive fungal infections in acute and chronic liver impairment: a systematic review. Mycoses. 2022;65(2):140\u2013151","journal-title":"Mycoses"},{"issue":"4","key":"11116_CR69","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-50","journal-title":"Clin Infect Dis"},{"issue":"4","key":"11116_CR70","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, et al. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1\u2013e60","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"11116_CR71","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1\u2013e38","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"11116_CR72","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/myc.13170","volume":"63","author":"V Cento","year":"2020","unstructured":"Cento V, et al. Quantification of 1,3-\u03b2-d-glucan by Wako \u03b2-glucan assay for rapid exclusion of invasive fungal infections in critical patients: a diagnostic test accuracy study. Mycoses. 2020;63(12):1299\u20131310","journal-title":"Mycoses"},{"issue":"1","key":"11116_CR73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4254\/wjh.v15.i1.41","volume":"15","author":"P Liptak","year":"2023","unstructured":"Liptak P, et al. Acute-on-chronic liver failure in patients with severe acute respiratory syndrome coronavirus 2 infection. World J Hepatol. 2023;15(1):41\u201351","journal-title":"World J Hepatol"},{"issue":"6","key":"11116_CR74","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12664-015-0613-0","volume":"34","author":"E Gupta","year":"2015","unstructured":"Gupta E, et al. Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults. Indian J Gastroenterol. 2015;34(6):448\u2013452","journal-title":"Indian J Gastroenterol"},{"issue":"1","key":"11116_CR75","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12879-018-3488-8","volume":"18","author":"J Hu","year":"2018","unstructured":"Hu J, et al. Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure. BMC Infect Dis. 2018;18(1):577","journal-title":"BMC Infect Dis"},{"key":"11116_CR76","doi-asserted-by":"crossref","unstructured":"Dibos M, et al. Herpes simplex virus bronchopneumonitis in critically ill patients with acute on chronic liver failure: a retrospective analysis. Viruses. 2024;16(3)","DOI":"10.3390\/v16030419"},{"issue":"3","key":"11116_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15733","volume":"45","author":"S Piano","year":"2025","unstructured":"Piano S, et al. Mechanisms and treatment approaches for ACLF. Liver Int. 2025;45(3): e15733","journal-title":"Liver Int"},{"key":"11116_CR78","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3389\/fimmu.2019.01155","volume":"10","author":"ARK Patro","year":"2019","unstructured":"Patro ARK. Subversion of immune response by human cytomegalovirus. Front Immunol. 2019;10:1155","journal-title":"Front Immunol"},{"key":"11116_CR79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.antiviral.2013.10.011","volume":"101","author":"TE Komatsu","year":"2014","unstructured":"Komatsu TE, et al. Resistance of human cytomegalovirus to ganciclovir\/valganciclovir: a comprehensive review of putative resistance pathways. Antivir Res. 2014;101:12\u201325","journal-title":"Antivir Res"},{"issue":"4","key":"11116_CR80","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1053\/gast.2002.32364","volume":"122","author":"R Moreau","year":"2002","unstructured":"Moreau R, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology. 2002;122(4):923\u2013930","journal-title":"Gastroenterology"},{"issue":"1","key":"11116_CR81","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/hep.30592","volume":"70","author":"P Huelin","year":"2019","unstructured":"Huelin P, et al. Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study. Hepatology. 2019;70(1):319\u2013333","journal-title":"Hepatology"},{"issue":"6","key":"11116_CR82","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort P, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341(6):403\u2013409","journal-title":"N Engl J Med"},{"issue":"2","key":"11116_CR83","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/hep.30208","volume":"71","author":"V Arora","year":"2020","unstructured":"Arora V, et al. Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure. Hepatology. 2020;71(2):600\u2013610","journal-title":"Hepatology"},{"issue":"5","key":"11116_CR84","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","volume":"134","author":"AJ Sanyal","year":"2008","unstructured":"Sanyal AJ, et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology. 2008;134(5):1360\u20131368","journal-title":"Gastroenterology"},{"issue":"7","key":"11116_CR85","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","volume":"150","author":"TD Boyer","year":"2016","unstructured":"Boyer TD, et al. Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1. Gastroenterology. 2016;150(7):1579-1589.e2","journal-title":"Gastroenterology"},{"issue":"12","key":"11116_CR86","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1111\/liv.15413","volume":"42","author":"R Maiwall","year":"2022","unstructured":"Maiwall R, et al. Natural history, spectrum and outcome of stage 3 AKI in patients with acute-on-chronic liver failure. Liver Int. 2022;42(12):2800\u20132814","journal-title":"Liver Int"},{"issue":"5","key":"11116_CR87","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/hep.32799","volume":"77","author":"C Gambino","year":"2023","unstructured":"Gambino C, et al. Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury. Hepatology. 2023;77(5):1630\u20131638","journal-title":"Hepatology"},{"issue":"1","key":"11116_CR88","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12072-024-10749-4","volume":"19","author":"R Maiwall","year":"2025","unstructured":"Maiwall R, et al. AARC score and urine NGAL predict terlipressin non-response and mortality in patients with acute-on-chronic liver failure. Hepatol Int. 2025;19(1):222\u2013233","journal-title":"Hepatol Int"},{"issue":"1\u20133","key":"11116_CR89","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000334149","volume":"33","author":"TA Gonwa","year":"2012","unstructured":"Gonwa TA, Wadei HM. The challenges of providing renal replacement therapy in decompensated liver cirrhosis. Blood Purif. 2012;33(1\u20133):144\u2013148","journal-title":"Blood Purif"},{"issue":"4","key":"11116_CR90","doi-asserted-by":"publisher","first-page":"R162","DOI":"10.1186\/cc11485","volume":"16","author":"C Schulthei\u00df","year":"2012","unstructured":"Schulthei\u00df C, et al. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care. 2012;16(4):R162","journal-title":"Crit Care"},{"issue":"5","key":"11116_CR91","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/cc11492","volume":"16","author":"S Patel","year":"2012","unstructured":"Patel S, Wendon J. Regional citrate anticoagulation in patients with liver failure\u2013time for a rethink? Crit Care. 2012;16(5):153","journal-title":"Crit Care"},{"issue":"8s","key":"11116_CR92","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.cgh.2022.04.035","volume":"20","author":"JS Bajaj","year":"2022","unstructured":"Bajaj JS, et al. Specific challenges in geriatric cirrhosis and hepatic encephalopathy. Clin Gastroenterol Hepatol. 2022;20(8s):S20-s29","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"11116_CR93","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41575-021-00527-0","volume":"19","author":"JP Arab","year":"2022","unstructured":"Arab JP, et al. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation. Nat Rev Gastroenterol Hepatol. 2022;19(1):45\u201359","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"11116_CR94","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.53965","volume":"7","author":"JS Bajaj","year":"2024","unstructured":"Bajaj JS, et al. Undiagnosed cirrhosis and hepatic encephalopathy in a national cohort of veterans with dementia. JAMA Netw Open. 2024;7(1): e2353965","journal-title":"JAMA Netw Open"},{"issue":"11","key":"11116_CR95","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.amjmed.2024.06.014","volume":"137","author":"S Silvey","year":"2024","unstructured":"Silvey S, et al. A possible reversible cause of cognitive impairment: undiagnosed cirrhosis and potential hepatic encephalopathy in patients with dementia. Am J Med. 2024;137(11):1082-1087.e1","journal-title":"Am J Med"},{"issue":"6","key":"11116_CR96","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/hep.21838","volume":"46","author":"W Bernal","year":"2007","unstructured":"Bernal W, et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46(6):1844\u20131852","journal-title":"Hepatology"},{"issue":"6","key":"11116_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100757","volume":"27","author":"P Vidal-Cevallos","year":"2022","unstructured":"Vidal-Cevallos P, Chavez-Tapia NC, Uribe M. Current approaches to hepatic encephalopathy. Ann Hepatol. 2022;27(6): 100757","journal-title":"Ann Hepatol"},{"key":"11116_CR98","doi-asserted-by":"crossref","unstructured":"Montagnese S, et al. EASL clinical practice guidelines on the management of hepatic encephalopathy. J Hepatol. 2022;77(3):807\u2013824.","DOI":"10.1016\/j.jhep.2022.06.001"},{"issue":"4","key":"11116_CR99","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.cgh.2022.03.046","volume":"21","author":"JS Bajaj","year":"2023","unstructured":"Bajaj JS, et al. Admission serum metabolites and thyroxine predict advanced hepatic encephalopathy in a multicenter inpatient cirrhosis cohort. Clin Gastroenterol Hepatol. 2023;21(4):1031-1040 e3","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"11116_CR100","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.gastha.2023.09.009","volume":"3","author":"AV Kulkarni","year":"2024","unstructured":"Kulkarni AV, et al. Thyroxine levels predict the development of brain failure in patients with cirrhosis in indian population. Gastro Hep Adv. 2024;3(1):55\u201357","journal-title":"Gastro Hep Adv"},{"issue":"6","key":"11116_CR101","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1053\/j.gastro.2015.07.067","volume":"149","author":"J Ampuero","year":"2015","unstructured":"Ampuero J, et al. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis. Gastroenterology. 2015;149(6):1483\u20131489","journal-title":"Gastroenterology"},{"issue":"10","key":"11116_CR102","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/lt.24517","volume":"22","author":"C Lucidi","year":"2016","unstructured":"Lucidi C, et al. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: evidence by means of 2 independent cohorts. Liver Transpl. 2016;22(10):1333\u20131342","journal-title":"Liver Transpl"},{"issue":"12","key":"11116_CR103","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/lt.26099","volume":"27","author":"C Acharya","year":"2021","unstructured":"Acharya C, Bajaj JS. Hepatic encephalopathy and liver transplantation: the past, present, and future toward equitable access. Liver Transpl. 2021;27(12):1830\u20131843","journal-title":"Liver Transpl"},{"issue":"2","key":"11116_CR104","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jhep.2022.09.009","volume":"78","author":"A Fagan","year":"2023","unstructured":"Fagan A, et al. A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study. J Hepatol. 2023;78(2):312\u2013321","journal-title":"J Hepatol"},{"issue":"5","key":"11116_CR105","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.32255","volume":"75","author":"A Jain","year":"2022","unstructured":"Jain A, et al. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: a double-blind randomized controlled trial. Hepatology. 2022;75(5):1194\u20131203","journal-title":"Hepatology"},{"issue":"7","key":"11116_CR106","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.cgh.2022.10.023","volume":"21","author":"JS Bajaj","year":"2023","unstructured":"Bajaj JS, et al. Role of oral health, frailty, and minimal hepatic encephalopathy in the risk of hospitalization: a prospective multi-center cohort of outpatients with cirrhosis. Clin Gastroenterol Hepatol. 2023;21(7):1864-1872.e2","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"11116_CR107","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/apt.17695","volume":"58","author":"K Kajal","year":"2023","unstructured":"Kajal K, et al. Cirrhotic cardiomyopathy influences clinical outcomes and enhances performance of conventional risk prediction models in acute-on-chronic liver failure with severe sepsis. Aliment Pharmacol Ther. 2023;58(9):903\u2013919","journal-title":"Aliment Pharmacol Ther"},{"key":"11116_CR108","doi-asserted-by":"crossref","unstructured":"Premkumar M, et al. Role of point-of-care ultrasound (POCUS) in clinical hepatology. Hepatology. 2024","DOI":"10.1097\/HEP.0000000000000990"},{"issue":"16","key":"11116_CR109","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.jacc.2025.02.018","volume":"85","author":"SS Sinha","year":"2025","unstructured":"Sinha SS, et al. 2025 concise clinical guidance: an ACC expert consensus statement on the evaluation and management of cardiogenic shock: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2025;85(16):1618\u20131641","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"11116_CR110","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1055\/a-2515-2783","volume":"45","author":"M Premkumar","year":"2025","unstructured":"Premkumar M, et al. Current concepts in fluid resuscitation and vasopressor use in cirrhosis. Semin Liver Dis. 2025;45(2):252\u2013268","journal-title":"Semin Liver Dis"},{"issue":"4","key":"11116_CR111","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0735-1097(01)01108-1","volume":"37","author":"AM Dart","year":"2001","unstructured":"Dart AM, Kingwell BA. Pulse pressure\u2014a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001;37(4):975\u2013984","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"11116_CR112","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12072-021-10164-z","volume":"15","author":"CA Philips","year":"2021","unstructured":"Philips CA, et al. Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial. Hepatol Int. 2021;15(4):983\u2013994","journal-title":"Hepatol Int"},{"issue":"3","key":"11116_CR113","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2022.03.043","volume":"77","author":"R Maiwall","year":"2022","unstructured":"Maiwall R, et al. A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. J Hepatol. 2022;77(3):670\u2013682","journal-title":"J Hepatol"},{"issue":"1","key":"11116_CR114","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13054-023-04587-3","volume":"27","author":"W Hu","year":"2023","unstructured":"Hu W, et al. Identification of indications for albumin administration in septic patients with liver cirrhosis. Crit Care. 2023;27(1):300","journal-title":"Crit Care"},{"issue":"6","key":"11116_CR115","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00134-024-07369-9","volume":"50","author":"YM Arabi","year":"2024","unstructured":"Arabi YM, et al. European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids. Intensive Care Med. 2024;50(6):813\u2013831","journal-title":"Intensive Care Med"},{"issue":"5","key":"11116_CR116","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","volume":"59","author":"K Oettl","year":"2013","unstructured":"Oettl K, et al. Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival. J Hepatol. 2013;59(5):978\u2013983","journal-title":"J Hepatol"},{"issue":"2","key":"11116_CR117","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.22913","volume":"50","author":"R Jalan","year":"2009","unstructured":"Jalan R, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology. 2009;50(2):555\u2013564","journal-title":"Hepatology"},{"issue":"2","key":"11116_CR118","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jhep.2023.04.006","volume":"79","author":"R Maiwall","year":"2023","unstructured":"Maiwall R, et al. A randomised-controlled trial (TARGET-C) of high vs. low target mean arterial pressure in patients with cirrhosis and septic shock. J Hepatol. 2023;79(2):349\u2013361","journal-title":"J Hepatol"},{"key":"11116_CR119","doi-asserted-by":"crossref","unstructured":"Smith TN, et al., Serum lactate and mean arterial pressure thresholds in patients with cirrhosis and septic shock. Hepatol Commun. 2024;8(1)","DOI":"10.1097\/HC9.0000000000000353"},{"issue":"5","key":"11116_CR120","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/hep.31199","volume":"72","author":"N Sarmast","year":"2020","unstructured":"Sarmast N, et al. Model for end-stage liver disease-lactate and prediction of inpatient mortality in patients with chronic liver disease. Hepatology. 2020;72(5):1747\u20131757","journal-title":"Hepatology"},{"issue":"4","key":"11116_CR121","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ams2.207","volume":"3","author":"S Kushimoto","year":"2016","unstructured":"Kushimoto S, et al. Lactate, a useful marker for disease mortality and severity but an unreliable marker of tissue hypoxia\/hypoperfusion in critically ill patients. Acute Med Surg. 2016;3(4):293\u2013297","journal-title":"Acute Med Surg"},{"issue":"1","key":"11116_CR122","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2110-5820-3-12","volume":"3","author":"J Bakker","year":"2013","unstructured":"Bakker J, Nijsten MW, Jansen TC. Clinical use of lactate monitoring in critically ill patients. Ann Intensive Care. 2013;3(1):12","journal-title":"Ann Intensive Care"},{"issue":"1","key":"11116_CR123","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/hep.30151","volume":"69","author":"A Drolz","year":"2019","unstructured":"Drolz A, et al. Lactate improves prediction of short-term mortality in critically ill patients with cirrhosis: a multinational study. Hepatology. 2019;69(1):258\u2013269","journal-title":"Hepatology"},{"issue":"13","key":"11116_CR124","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.18632\/aging.102062","volume":"11","author":"F Gao","year":"2019","unstructured":"Gao F, et al. Prognostic value of serum lactate kinetics in critically ill patients with cirrhosis and acute-on-chronic liver failure: a multicenter study. Aging (Albany NY). 2019;11(13):4446\u20134462","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"11116_CR125","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/HEP.0000000000000530","volume":"79","author":"EW Lee","year":"2024","unstructured":"Lee EW, et al. AASLD practice guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage. Hepatology. 2024;79(1):224\u2013250","journal-title":"Hepatology"},{"issue":"4","key":"11116_CR126","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, et al. Baveno VII\u2014renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959\u2013974","journal-title":"J Hepatol"},{"issue":"5","key":"11116_CR127","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jhep.2020.04.024","volume":"73","author":"J Trebicka","year":"2020","unstructured":"Trebicka J, et al. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. J Hepatol. 2020;73(5):1082\u20131091","journal-title":"J Hepatol"},{"issue":"1","key":"11116_CR128","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jhep.2020.06.010","volume":"74","author":"R Kumar","year":"2021","unstructured":"Kumar R, et al. Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding. J Hepatol. 2021;74(1):66\u201379","journal-title":"J Hepatol"},{"key":"11116_CR129","unstructured":"Yu X, et al., The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution. Hepatol Commun. 2024;8(1)"},{"issue":"3","key":"11116_CR130","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15670","volume":"45","author":"R Hernaez","year":"2025","unstructured":"Hernaez R, et al. Definition, diagnosis and epidemiology of acute-on-chronic liver failure. Liver Int. 2025;45(3): e15670","journal-title":"Liver Int"},{"issue":"11","key":"11116_CR131","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.cgh.2024.04.018","volume":"22","author":"A Aggarwal","year":"2024","unstructured":"Aggarwal A, et al. Definitions, etiologies, and outcomes of acute on chronic liver failure: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2024;22(11):2199-2210.e25","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"11116_CR132","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/gutjnl-2020-322161","volume":"71","author":"G Mezzano","year":"2022","unstructured":"Mezzano G, et al. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut. 2022;71(1):148\u2013155","journal-title":"Gut"},{"issue":"3","key":"11116_CR133","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","volume":"13","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol. 2016;13(3):131\u2013149","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"11116_CR134","first-page":"210","volume":"9","author":"M Premkumar","year":"2021","unstructured":"Premkumar M, et al. Clinical validation of global coagulation tests to guide blood component transfusions in cirrhosis and ACLF. J Clin Transl Hepatol. 2021;9(2):210\u2013219","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"11116_CR135","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s12072-020-10036-y","volume":"14","author":"C Bihari","year":"2020","unstructured":"Bihari C, et al. Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and ACLF patients. Hepatol Int. 2020;14(4):597\u2013608","journal-title":"Hepatol Int"},{"issue":"1","key":"11116_CR136","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12876-020-01413-w","volume":"20","author":"J See\u00dfle","year":"2020","unstructured":"See\u00dfle J, et al. Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients. BMC Gastroenterol. 2020;20(1):271","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"11116_CR137","first-page":"71","volume":"37","author":"G Kampelos","year":"2024","unstructured":"Kampelos G, et al. Serial rotational thromboelastometry measurements show worsening hypocoagulability in acute-on-chronic liver failure and are associated with the severity of liver disease. Ann Gastroenterol. 2024;37(1):71\u201380","journal-title":"Ann Gastroenterol"},{"issue":"6","key":"11116_CR138","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/hep.30103","volume":"68","author":"A Blasi","year":"2018","unstructured":"Blasi A, et al. Coagulation failure in patients with acute-on-chronic liver failure and decompensated cirrhosis: beyond the international normalized ratio. Hepatology. 2018;68(6):2325\u20132337","journal-title":"Hepatology"},{"issue":"4","key":"11116_CR139","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/liv.14034","volume":"39","author":"M Premkumar","year":"2019","unstructured":"Premkumar M, et al. Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure: an observational cohort study. Liver Int. 2019;39(4):694\u2013704","journal-title":"Liver Int"},{"issue":"4","key":"11116_CR140","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/cld.976","volume":"16","author":"M Premkumar","year":"2020","unstructured":"Premkumar M, Sarin SK. Current concepts in coagulation profile in cirrhosis and acute-on-chronic liver failure. Clin Liver Dis (Hoboken). 2020;16(4):158\u2013167","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"1","key":"11116_CR141","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/MEG.0000000000002630","volume":"36","author":"G Kampelos","year":"2024","unstructured":"Kampelos G, et al. A combination of clot formation abnormalities in thromboelastometry has a high prognostic value in patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol. 2024;36(1):76\u201382","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"11116_CR142","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jceh.2021.05.001","volume":"12","author":"M Premkumar","year":"2022","unstructured":"Premkumar M, et al. Principles, interpretation, and evidence-based role of viscoelastic point-of-care coagulation assays in cirrhosis and liver failure. J Clin Exp Hepatol. 2022;12(2):533\u2013543","journal-title":"J Clin Exp Hepatol"},{"key":"11116_CR143","unstructured":"V SV, et al. Rotational thromboelastometry helped reduce prophylactic blood product use for port insertion in patients with liver failure undergoing plasma exchange. Indian J Gastroenterol. 2025"},{"issue":"5","key":"11116_CR144","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/liv.14806","volume":"41","author":"R Maiwall","year":"2021","unstructured":"Maiwall R, et al. Therapeutic plasma-exchange improves systemic inflammation and survival in acute-on-chronic liver failure: a propensity-score matched study from AARC. Liver Int. 2021;41(5):1083\u20131096","journal-title":"Liver Int"},{"issue":"6","key":"11116_CR145","doi-asserted-by":"publisher","first-page":"481","DOI":"10.5223\/pghn.2022.25.6.481","volume":"25","author":"H Lim","year":"2022","unstructured":"Lim H, et al. Effectiveness of high-volume therapeutic plasma exchange for acute and acute-on-chronic liver failure in korean pediatric patients. Pediatr Gastroenterol Hepatol Nutr. 2022;25(6):481\u2013488","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"8","key":"11116_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2023.102206","volume":"47","author":"I Kounis","year":"2023","unstructured":"Kounis I, et al. Efficiency and safety of total plasma exchange in critically ill cirrhotic patients with acute on chronic liver failure: a pilot study. Clin Res Hepatol Gastroenterol. 2023;47(8): 102206","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"6","key":"11116_CR147","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/jca.22010","volume":"37","author":"S Ramakrishnan","year":"2022","unstructured":"Ramakrishnan S, et al. Therapeutic plasma exchange is a safe and effective bridge therapy in patients with alcohol-associated ACLF not having immediate prospects for liver transplantation-a case-control, pilot study. J Clin Apher. 2022;37(6):553\u2013562","journal-title":"J Clin Apher"},{"issue":"2","key":"11116_CR148","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/LVT.0000000000000231","volume":"30","author":"A Beran","year":"2024","unstructured":"Beran A, et al. Plasma exchange for acute and acute-on-chronic liver failure: a systematic review and meta-analysis. Liver Transpl. 2024;30(2):127\u2013141","journal-title":"Liver Transpl"},{"issue":"5","key":"11116_CR149","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70018","volume":"45","author":"SE Kumar","year":"2025","unstructured":"Kumar SE, et al. Therapeutic plasma exchange in patients with acute-on-chronic liver failure improves survival-an updated meta-analysis. Liver Int. 2025;45(5): e70018","journal-title":"Liver Int"},{"key":"11116_CR150","doi-asserted-by":"crossref","unstructured":"Swaroop S, et al. Therapeutic plasma exchange improves short-term survival in patients with acute-on-chronic liver failure: a randomized controlled trial. Hepatology. 2026","DOI":"10.1097\/HEP.0000000000001755"},{"issue":"2","key":"11116_CR151","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3748\/wjg.v26.i2.219","volume":"26","author":"EX Tan","year":"2020","unstructured":"Tan EX, et al. Plasma exchange in patients with acute and acute-on-chronic liver failure: a systematic review. World J Gastroenterol. 2020;26(2):219\u2013245","journal-title":"World J Gastroenterol"},{"issue":"4","key":"11116_CR152","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/jca.22033","volume":"38","author":"S Swaroop","year":"2023","unstructured":"Swaroop S, et al. Therapeutic plasma-exchange improves short-term, but not long-term, outcomes in patients with acute-on-chronic liver failure: a propensity score-matched analysis. J Clin Apher. 2023;38(4):376\u2013389","journal-title":"J Clin Apher"},{"issue":"4","key":"11116_CR153","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/jca.21799","volume":"35","author":"K Stahl","year":"2020","unstructured":"Stahl K, et al. Therapeutic plasma exchange in acute on chronic liver failure. J Clin Apher. 2020;35(4):316\u2013327","journal-title":"J Clin Apher"},{"issue":"6","key":"11116_CR154","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/hepr.13497","volume":"50","author":"L Yang","year":"2020","unstructured":"Yang L, et al. Artificial liver treatment improves survival in patients with hepatitis B virus-related acute-on-chronic liver failure: a case-control matched analysis. Hepatol Res. 2020;50(6):656\u2013670","journal-title":"Hepatol Res"},{"issue":"1","key":"11116_CR155","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13054-023-04540-4","volume":"27","author":"J Luo","year":"2023","unstructured":"Luo J, et al. Acute-on-chronic liver failure: far to go-a review. Crit Care. 2023;27(1):259","journal-title":"Crit Care"},{"issue":"1","key":"11116_CR156","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13613-018-0453-z","volume":"8","author":"JJ Garc\u00eda Mart\u00ednez","year":"2018","unstructured":"Garc\u00eda Mart\u00ednez JJ, Bendjelid K. Artificial liver support systems: what is new over the last decade? Ann Intensive Care. 2018;8(1):109","journal-title":"Ann Intensive Care"},{"issue":"12","key":"11116_CR157","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","volume":"67","author":"T Wu","year":"2018","unstructured":"Wu T, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67(12):2181\u20132191","journal-title":"Gut"},{"issue":"5","key":"11116_CR158","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2021.05.026","volume":"75","author":"J Li","year":"2021","unstructured":"Li J, et al. Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure. J Hepatol. 2021;75(5):1104\u20131115","journal-title":"J Hepatol"},{"issue":"8","key":"11116_CR159","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1177\/0391398820981383","volume":"44","author":"D Tomescu","year":"2021","unstructured":"Tomescu D, et al. Haemoadsorption by CytoSorb\u00ae in patients with acute liver failure: a case series. Int J Artif Organs. 2021;44(8):560\u2013564","journal-title":"Int J Artif Organs"},{"issue":"1","key":"11116_CR160","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13613-023-01198-7","volume":"13","author":"A Greimel","year":"2023","unstructured":"Greimel A, et al. Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study. Ann Intensive Care. 2023;13(1):110","journal-title":"Ann Intensive Care"},{"issue":"10","key":"11116_CR161","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/aor.14774","volume":"48","author":"A Sekandarzad","year":"2024","unstructured":"Sekandarzad A, et al. Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP): a single center, open-label, three-arm, randomized, controlled intervention pilot trial. Artif Organs. 2024;48(10):1150\u20131161","journal-title":"Artif Organs"},{"key":"11116_CR162","unstructured":"Yarrarapu SNS, Sanghavi DK. Molecular absorbent recirculating system. In: StatPearls. 2026; Treasure Island"},{"issue":"6","key":"11116_CR163","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s12072-019-09992-x","volume":"13","author":"T Chen","year":"2019","unstructured":"Chen T, et al. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region. Hepatol Int. 2019;13(6):695\u2013705","journal-title":"Hepatol Int"},{"issue":"2","key":"11116_CR164","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jhep.2015.03.018","volume":"63","author":"N Zhou","year":"2015","unstructured":"Zhou N, et al. Efficacy of coupled low-volume plasma exchange with plasma filtration adsorption in treating pigs with acute liver failure: a randomised study. J Hepatol. 2015;63(2):378\u2013387","journal-title":"J Hepatol"},{"issue":"10","key":"11116_CR165","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1007\/s00134-022-06802-1","volume":"48","author":"F Saliba","year":"2022","unstructured":"Saliba F, et al. Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts. Intensive Care Med. 2022;48(10):1352\u20131367","journal-title":"Intensive Care Med"},{"issue":"1","key":"11116_CR166","doi-asserted-by":"publisher","first-page":"7510","DOI":"10.1038\/s41598-021-87055-8","volume":"11","author":"J Shang","year":"2021","unstructured":"Shang J, et al. A novel prognostic model to predict outcome of artificial liver support system treatment. Sci Rep. 2021;11(1):7510","journal-title":"Sci Rep"},{"key":"11116_CR167","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/IDR.S500291","volume":"18","author":"K Cui","year":"2025","unstructured":"Cui K, et al. Association between artificial liver support system and prognosis in hepatitis B virus-related acute-on-chronic liver failure. Infect Drug Resist. 2025;18:113\u2013126","journal-title":"Infect Drug Resist"},{"issue":"1","key":"11116_CR168","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jceh.2020.09.003","volume":"11","author":"P Puri","year":"2021","unstructured":"Puri P, et al. Nutrition in chronic liver disease: consensus statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol. 2021;11(1):97\u2013143","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"11116_CR169","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.24418","volume":"54","author":"A Berzigotti","year":"2011","unstructured":"Berzigotti A, et al. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology. 2011;54(2):555\u2013561","journal-title":"Hepatology"},{"issue":"1","key":"11116_CR170","doi-asserted-by":"publisher","first-page":"2473627","DOI":"10.1080\/07853890.2025.2473627","volume":"57","author":"Z Wen","year":"2025","unstructured":"Wen Z, et al. Effect of adipose-related parameters on mortality in patients with liver cirrhosis: a meta-analysis. Ann Med. 2025;57(1):2473627","journal-title":"Ann Med"},{"issue":"8","key":"11116_CR171","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2169\/internalmedicine.55.6298","volume":"55","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Nishiguchi S. Sarcopenia and sarcopenic obesity are prognostic factors for overall survival in patients with cirrhosis. Intern Med. 2016;55(8):855\u2013856","journal-title":"Intern Med"},{"issue":"5","key":"11116_CR172","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1177\/0884533612446195","volume":"27","author":"C Glass","year":"2012","unstructured":"Glass C, et al. Handheld calorimeter is a valid instrument to quantify resting energy expenditure in hospitalized cirrhotic patients: a prospective study. Nutr Clin Pract. 2012;27(5):677\u2013688","journal-title":"Nutr Clin Pract"},{"issue":"1","key":"11116_CR173","first-page":"65","volume":"31","author":"W Wang","year":"2023","unstructured":"Wang W, et al. Comparison of three different measurement methods to determine resting energy expenditure in patients with decompensated hepatitis B cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2023;31(1):65\u201369","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"3","key":"11116_CR174","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/hep.32049","volume":"74","author":"JC Lai","year":"2021","unstructured":"Lai JC, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(3):1611\u20131644","journal-title":"Hepatology"},{"key":"11116_CR175","first-page":"1267","volume":"10","author":"S Goisser","year":"2015","unstructured":"Goisser S, et al. Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons\u2014a narrative review. Clin Interv Aging. 2015;10:1267\u20131282","journal-title":"Clin Interv Aging"},{"issue":"11","key":"11116_CR176","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1016\/j.clnu.2020.02.023","volume":"39","author":"P Schuetz","year":"2020","unstructured":"Schuetz P, et al. Economic evaluation of individualized nutritional support in medical inpatients: Secondary analysis of the EFFORT trial. Clin Nutr. 2020;39(11):3361\u20133368","journal-title":"Clin Nutr"},{"issue":"1","key":"11116_CR177","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jhep.2004.03.023","volume":"41","author":"J C\u00f3rdoba","year":"2004","unstructured":"C\u00f3rdoba J, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol. 2004;41(1):38\u201343","journal-title":"J Hepatol"},{"issue":"2","key":"11116_CR178","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/0148607115621863","volume":"40","author":"SA McClave","year":"2016","unstructured":"McClave SA, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159\u2013211","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"3","key":"11116_CR179","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jhep.2021.11.006","volume":"76","author":"X Tantai","year":"2022","unstructured":"Tantai X, et al. Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;76(3):588\u2013599","journal-title":"J Hepatol"},{"issue":"4","key":"11116_CR180","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000025","volume":"10","author":"M Praktiknjo","year":"2019","unstructured":"Praktiknjo M, et al. Sarcopenia is associated with development of acute-on-chronic liver failure in decompensated liver cirrhosis receiving transjugular intrahepatic portosystemic shunt. Clin Transl Gastroenterol. 2019;10(4): e00025","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"11116_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100985","volume":"6","author":"GG Perdiguero","year":"2024","unstructured":"Perdiguero GG, et al. Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list. JHEP Rep. 2024;6(3): 100985","journal-title":"JHEP Rep"},{"issue":"7","key":"11116_CR182","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1097\/TP.0000000000003222","volume":"104","author":"E Mauro","year":"2020","unstructured":"Mauro E, et al. Cystatin C and sarcopenia predict acute on chronic liver failure development and mortality in patients on the liver transplant waiting list. Transplantation. 2020;104(7):e188\u2013e198","journal-title":"Transplantation"},{"issue":"4","key":"11116_CR183","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s12072-022-10363-2","volume":"16","author":"H Peng","year":"2022","unstructured":"Peng H, et al. A prognostic model of acute-on-chronic liver failure based on sarcopenia. Hepatol Int. 2022;16(4):964\u2013972","journal-title":"Hepatol Int"},{"issue":"8","key":"11116_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100758","volume":"5","author":"T Mangana Del Rio","year":"2023","unstructured":"Mangana Del Rio T, et al. Body composition and short-term mortality in patients critically ill with acute-on-chronic liver failure. JHEP Rep. 2023;5(8): 100758","journal-title":"JHEP Rep"},{"issue":"4","key":"11116_CR185","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/jcsm.13501","volume":"15","author":"F Zeng","year":"2024","unstructured":"Zeng F, et al. Sarcopenia is associated with short- and long-term mortality in patients with acute-on-chronic liver failure. J Cachexia Sarcopenia Muscle. 2024;15(4):1473\u20131482","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"11116_CR186","doi-asserted-by":"publisher","first-page":"12593","DOI":"10.1038\/s41598-021-92087-1","volume":"11","author":"T Li","year":"2021","unstructured":"Li T, et al. Use of skeletal muscle index as a predictor of short-term mortality in patients with acute-on-chronic liver failure. Sci Rep. 2021;11(1):12593","journal-title":"Sci Rep"},{"key":"11116_CR187","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-2803.24612024-069","volume":"61","author":"LM Eifler","year":"2024","unstructured":"Eifler LM, et al. Impact of sarcopenia on the prognosis of patients with cirrhosis hospitalized for acute decompensation or acute-on-chronic liver failure. Arq Gastroenterol. 2024;61: e24069","journal-title":"Arq Gastroenterol"},{"issue":"2","key":"11116_CR188","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.70088","volume":"39","author":"GE Markakis","year":"2025","unstructured":"Markakis GE, et al. Sarcopenia as a predictor of survival and complications of patients with cirrhosis after liver transplantation: a systematic review and meta-analysis. Clin Transplant. 2025;39(2): e70088","journal-title":"Clin Transplant"},{"issue":"4","key":"11116_CR189","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.jhep.2021.09.004","volume":"76","author":"F Artru","year":"2022","unstructured":"Artru F, et al. Sarcopenia should be evaluated in patients with acute-on-chronic liver failure and candidates for liver transplantation. J Hepatol. 2022;76(4):983\u2013985","journal-title":"J Hepatol"},{"issue":"5","key":"11116_CR190","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jceh.2019.12.003","volume":"10","author":"V Kumar","year":"2020","unstructured":"Kumar V, et al. Sarcopenia in cirrhosis: fallout on liver transplantation. J Clin Exp Hepatol. 2020;10(5):467\u2013476","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"11116_CR191","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000490262","volume":"34","author":"J Trebicka","year":"2018","unstructured":"Trebicka J, Reiberger T, Laleman W. Gut-liver axis links portal hypertension to acute-on-chronic liver failure. Visc Med. 2018;34(4):270\u2013275","journal-title":"Visc Med"},{"issue":"6","key":"11116_CR192","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s12664-023-01450-9","volume":"42","author":"D Jothimani","year":"2023","unstructured":"Jothimani D, et al. Fecal calprotectin in patients with liver cirrhosis. Indian J Gastroenterol. 2023;42(6):818\u2013823","journal-title":"Indian J Gastroenterol"},{"issue":"6","key":"11116_CR193","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70119","volume":"45","author":"F Haedge","year":"2025","unstructured":"Haedge F, et al. Surrogate markers of intestinal permeability, bacterial translocation and gut-vascular barrier damage across stages of cirrhosis. Liver Int. 2025;45(6): e70119","journal-title":"Liver Int"},{"issue":"12","key":"11116_CR194","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass NM, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071\u20131081","journal-title":"N Engl J Med"},{"issue":"3","key":"11116_CR195","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/jgh.12070","volume":"28","author":"J Vlachogiannakos","year":"2013","unstructured":"Vlachogiannakos J, et al. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis. J Gastroenterol Hepatol. 2013;28(3):450\u2013455","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"11116_CR196","doi-asserted-by":"publisher","first-page":"864","DOI":"10.14309\/ajg.0000000000002575","volume":"119","author":"AV Kulkarni","year":"2024","unstructured":"Kulkarni AV, et al. Antibiotics with or without rifaximin for acute hepatic encephalopathy in critically ill patients with cirrhosis: a double-blind, randomized controlled (ARiE) trial. Am J Gastroenterol. 2024;119(5):864\u2013874","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"11116_CR197","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","volume":"67","author":"R Wiest","year":"2017","unstructured":"Wiest R, et al. Targeting the gut-liver axis in liver disease. J Hepatol. 2017;67(5):1084\u20131103","journal-title":"J Hepatol"},{"issue":"4","key":"11116_CR198","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.70148","volume":"9","author":"A Malvi","year":"2025","unstructured":"Malvi A, et al. Impact of quinolone prophylaxis on spontaneous bacterial peritonitis and mortality in cirrhosis patients: a systematic review and meta-analysis of randomized controlled trials. JGH Open. 2025;9(4): e70148","journal-title":"JGH Open"},{"issue":"2","key":"11116_CR199","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12072-022-10312-z","volume":"16","author":"A Sharma","year":"2022","unstructured":"Sharma A, et al. Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial. Hepatol Int. 2022;16(2):433\u2013446","journal-title":"Hepatol Int"},{"issue":"21","key":"11116_CR200","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med. 2019;381(21):2043\u20132050","journal-title":"N Engl J Med"},{"key":"11116_CR201","unstructured":"Administration USFaD. Important safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse reactions due to transmission of multi-drug resistant organisms. 2019. https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/fecal-microbiota-transplantation-safety-communication-risk-serious-adverse-reactions-due. Cited 17 Apr 2026"},{"key":"11116_CR202","unstructured":"U.S. Food and Drug Administration. Safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse events likely due to transmission of pathogenic organisms. 2020. https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/fecal-microbiota-transplantation-safety-alert-risk-serious-adverse-events-likely-due-transmission. Cited 17 Apr 2026"},{"issue":"1","key":"11116_CR203","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhepr.2019.02.008","volume":"1","author":"F Artru","year":"2019","unstructured":"Artru F, Samuel D. Approaches for patients with very high MELD scores. JHEP Rep. 2019;1(1):53\u201365","journal-title":"JHEP Rep"},{"issue":"4","key":"11116_CR204","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/lt.25426","volume":"25","author":"JG O'Leary","year":"2019","unstructured":"O\u2019Leary JG, et al. Outcomes after listing for liver transplant in patients with acute-on-chronic liver failure: the multicenter North American Consortium for the study of end-stage liver disease experience. Liver Transpl. 2019;25(4):571\u2013579","journal-title":"Liver Transpl"},{"key":"11116_CR205","doi-asserted-by":"publisher","first-page":"13451","DOI":"10.3389\/ti.2024.13451","volume":"37","author":"LS Belli","year":"2024","unstructured":"Belli LS, et al. Liver transplantation in alcohol-associated hepatitis. Benefits and limitations of psychosocial selection and support in alcohol relapse. The experience of a Tertiary Center in Italy. Transpl Int. 2024;37:13451","journal-title":"Transpl Int"},{"issue":"4","key":"11116_CR206","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0041-0101(86)90196-0","volume":"24","author":"P Tungthanathanich","year":"1986","unstructured":"Tungthanathanich P, Chaiyabutr N, Sitprija V. Effect of Russell\u2019s viper (Vipera russelli siamensis) venom on renal hemodynamics in dogs. Toxicon. 1986;24(4):365\u2013371","journal-title":"Toxicon"},{"issue":"9","key":"11116_CR207","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s11605-015-2832-1","volume":"19","author":"MJ Chu","year":"2015","unstructured":"Chu MJ, et al. Donor hepatic steatosis and outcome after liver transplantation: a systematic review. J Gastrointest Surg. 2015;19(9):1713\u20131724","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"11116_CR208","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1053\/j.gastro.2019.04.012","volume":"157","author":"BP Lee","year":"2019","unstructured":"Lee BP, et al. Model to calculate harms and benefits of early vs delayed liver transplantation for patients with alcohol-associated hepatitis. Gastroenterology. 2019;157(2):472-480.e5","journal-title":"Gastroenterology"},{"issue":"3","key":"11116_CR209","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/lt.25395","volume":"25","author":"SK Yadav","year":"2019","unstructured":"Yadav SK, et al. Living donor liver transplantation for acute-on-chronic liver failure. Liver Transpl. 2019;25(3):459\u2013468","journal-title":"Liver Transpl"},{"issue":"1","key":"11116_CR210","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajt.2024.08.008","volume":"25","author":"HM Kwon","year":"2025","unstructured":"Kwon HM, et al. Benefits of liver transplant in critically ill patients with acute-on-chronic liver failure: Implementation of an urgent living-donor program. Am J Transpl. 2025;25(1):150\u2013163","journal-title":"Am J Transpl"},{"issue":"8","key":"11116_CR211","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14739","volume":"36","author":"T Toshima","year":"2022","unstructured":"Toshima T, et al. Outcomes of living-donor liver transplantation for acute-on-chronic liver failure based on newly proposed criteria in Japan. Clin Transplant. 2022;36(8): e14739","journal-title":"Clin Transplant"},{"issue":"5","key":"11116_CR212","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1053\/j.gastro.2018.12.007","volume":"156","author":"V Sundaram","year":"2019","unstructured":"Sundaram V, et al. Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation. Gastroenterology. 2019;156(5):1381-1391.e3","journal-title":"Gastroenterology"},{"issue":"9","key":"11116_CR213","first-page":"Cd014685","volume":"9","author":"SJ Tingle","year":"2023","unstructured":"Tingle SJ, et al. Machine perfusion in liver transplantation. Cochrane Database Syst Rev. 2023;9(9):Cd014685","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"11116_CR214","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.ajt.2024.03.026","volume":"24","author":"J Fern\u00e1ndez","year":"2024","unstructured":"Fern\u00e1ndez J, et al. Bridging the critically ill patient with acute to chronic liver failure to liver transplantation. Am J Transpl. 2024;24(8):1348\u20131361","journal-title":"Am J Transpl"},{"issue":"1","key":"11116_CR215","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","volume":"40","author":"T Restuccia","year":"2004","unstructured":"Restuccia T, et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol. 2004;40(1):140\u2013146","journal-title":"J Hepatol"},{"issue":"3","key":"11116_CR216","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/ajt.13631","volume":"16","author":"RN Formica","year":"2016","unstructured":"Formica RN, et al. Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources. Am J Transpl. 2016;16(3):758\u2013766","journal-title":"Am J Transpl"},{"issue":"5","key":"11116_CR217","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","volume":"156","author":"S Piano","year":"2019","unstructured":"Piano S, et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology. 2019;156(5):1368-1380.e10","journal-title":"Gastroenterology"},{"issue":"2","key":"11116_CR218","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","volume":"74","author":"F Wong","year":"2021","unstructured":"Wong F, et al. Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure. J Hepatol. 2021;74(2):330\u2013339","journal-title":"J Hepatol"},{"issue":"4","key":"11116_CR219","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22140","volume":"39","author":"L Zhang","year":"2024","unstructured":"Zhang L, et al. Comparative efficacy of double plasma molecular adsorption system combined with plasma exchange versus plasma exchange in treating acute-on-chronic liver failure due to hepatitis B: a meta-analysis. J Clin Apher. 2024;39(4): e22140","journal-title":"J Clin Apher"},{"issue":"3","key":"11116_CR220","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28650","volume":"95","author":"W Xu","year":"2023","unstructured":"Xu W, et al. Safety and efficacy of double plasma molecular adsorption system with sequential low-volume plasma exchange in intermediate-stage hepatitis B virus-related acute-on-chronic liver failure. J Med Virol. 2023;95(3): e28650","journal-title":"J Med Virol"},{"issue":"2","key":"11116_CR221","first-page":"433","volume":"11","author":"C Wu","year":"2023","unstructured":"Wu C, et al. Efficacy and economic evaluation of nonbiological artificial liver therapy in acute-on-chronic hepatitis B liver failure. J Clin Transl Hepatol. 2023;11(2):433\u2013440","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"11116_CR222","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jhep.2023.03.013","volume":"79","author":"B Agarwal","year":"2023","unstructured":"Agarwal B, et al. Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on-chronic liver failure. J Hepatol. 2023;79(1):79\u201392","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11116-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11116-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11116-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:01:55Z","timestamp":1787763715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-026-11116-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":222,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11116"],"URL":"https:\/\/doi.org\/10.1007\/s12072-026-11116-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors declare no competing interests for this manuscript.","order":1,"name":"Ethics","label":"Conflict of the interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}